Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Active not recruiting × BO-112 × Clear all

Phase

Status

Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 1

Interventions

pembrolizumab 164 Nivolumab 125 Carboplatin 105 Specimen Handling 103 Cyclophosphamide 97 Magnetic Resonance Spectroscopy 89 Paclitaxel 87 Biopsy 77 Dexamethasone 75 durvalumab 74 Radiotherapy 72 Cisplatin 72 atezolizumab 67 Ipilimumab 61 Lenalidomide 58 Gemcitabine 55 Rituximab 51 Docetaxel 51 olaparib 48 Doxorubicin 47 Bevacizumab 47 Oxaliplatin 43 Prednisone 41 Fluorouracil 41 Radiosurgery 38 Radiation 38 Etoposide 38 Capecitabine 38 Temozolomide 35 Leucovorin 35

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06422936 2026-01-26

SPOTLIGHT204

Highlight Therapeutics

Phase 2 Active not recruiting

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡